Track topics on Twitter Track topics that are important to you
Catalent Biologics, through its Paragon Gene Therapy business, has agreed to assume the leases to two Novavax facilities in Maryland, USA. The move, said Novavax, will reduce its operating costs and provide a cash payment of about $18 million, allowing the company to focus on advancing its NanoFlu and ResVax vaccines through the next phases of clinical development and regulatory review.
Original Article: Catalent Buys Facilities in US and ItalyNEXT ARTICLE
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...